Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
…, R Achkar, N Hamerschlak, P Scuracchio… - …, 2020 - Wiley Online Library
Background Coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP) collection
began in two Brazilian hospitals for treatment of severe/critical patients. Methods and …
began in two Brazilian hospitals for treatment of severe/critical patients. Methods and …
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and …
…, R Fachini, G Candelaria, P Scuracchio… - …, 2021 - Wiley Online Library
Introduction Little is known about the neutralizing (nAb) and binding antibody kinetics in
COVID‐19 convalescent plasma donors, especially during the first 100 days after disease onset. …
COVID‐19 convalescent plasma donors, especially during the first 100 days after disease onset. …
[HTML][HTML] Transfusion-transmitted malaria: case report of asymptomatic donor harboring Plasmodium malariae
P Scuracchio, SD Vieira, DA Dourado… - Revista do Instituto de …, 2011 - SciELO Brasil
Malaria in Brazil is endemic in the Amazon region, but autochthonous cases with low
parasitaemia occur in the Atlantic Forest area of the country. According to Brazilian legislation no …
parasitaemia occur in the Atlantic Forest area of the country. According to Brazilian legislation no …
Anti‐A and SARS‐CoV‐2: an intriguing association
…, LV Rizzo, AM Sakashita, P Scuracchio… - Vox …, 2021 - Wiley Online Library
Background Blood groups and anti‐A isohemagglutinin may be involved in susceptibility to
SARS‐CoV‐2 infection. Materials and Methods We retrospectively studied 268 COVID‐19 …
SARS‐CoV‐2 infection. Materials and Methods We retrospectively studied 268 COVID‐19 …
International forum on occult hepatitis B infection and transfusion safety
…, L Pomeroy, S Wendel, R Fachini, P Scuracchio… - Vox …, 2019 - Wiley Online Library
Although not mandatory in France, HBV-NAT has been implemented in overseas territories
in 2005, in Army services in 2006 and progressively in mainland France in 2010 when the …
in 2005, in Army services in 2006 and progressively in mainland France in 2010 when the …
International forum on the collection and use of COVID‐19 convalescent plasma: protocols, challenges and lessons learned: summary
…, R Chaurasia, RM Fachini, P Scuracchio… - Vox …, 2021 - Wiley Online Library
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory coronavirus 2 (SARS-CoV-2),
has rapidly spread since its first declaration by the World Health Organization (…
has rapidly spread since its first declaration by the World Health Organization (…
COVID‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes
…, R Achkar, MSC Assunção, P Scuracchio… - …, 2021 - Wiley Online Library
Background Current evidence regarding COVID‐19 convalescent plasma (CCP) transfusion
practices is limited and heterogeneous. We aimed to determine the impact of the use of …
practices is limited and heterogeneous. We aimed to determine the impact of the use of …
International forum on the collection and use of COVID‐19 convalescent plasma: responses
…, R Chaurasia, RM Fachini, P Scuracchio… - Vox …, 2021 - Wiley Online Library
Vitalant in Pittsburgh administers a centralized transfusion service that provides transfusion
medicine expertise and blood products to about 24 area hospitals. Between these hospitals, …
medicine expertise and blood products to about 24 area hospitals. Between these hospitals, …
[HTML][HTML] The 4-year experience with implementation and routine use of pathogen reduction in a Brazilian hospital
RM Fachini, R Fontão-Wendel, R Achkar, P Scuracchio… - Pathogens, 2021 - mdpi.com
(1) Background: We reviewed the logistics of the implementation of pathogen reduction (PR)
using the INTERCEPT Blood System™ for platelets and the experience with routine use …
using the INTERCEPT Blood System™ for platelets and the experience with routine use …
Surrogate test performance for SARS‐CoV‐2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
…, M Amaral, CP Soares, R Achkar, P Scuracchio… - …, 2021 - Wiley Online Library
Background COVID‐19 high‐titer CCP selection is a concern, because neutralizing antibody
(nAb) testing requires sophisticated labs and methods. Surrogate tests are an alternative …
(nAb) testing requires sophisticated labs and methods. Surrogate tests are an alternative …